Skip to menu Skip to content Skip to footer

2021

Journal Article

Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020

Obermair, Andreas, Beale, Philip, Scott, Clare L, Beshay, Victoria, Kichenadasse, Ganessan, Simcock, Bryony, Nicklin, James, Lee, Yeh Chen, Cohen, Paul and Meniawy, Tarek (2021). Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020. Journal of Gynecologic Oncology, 32 (6) e95, e95. doi: 10.3802/jgo.2021.32.e95

Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020

2021

Journal Article

The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer

Cibula, David, Dostálek, Lukáš, Jarkovsky, Jiri, Mom, Constantijne H., Lopez, Aldo, Falconer, Henrik, Fagotti, Anna, Ayhan, Ali, Kim, Sarah H., Isla Ortiz, David, Klat, Jaroslav, Obermair, Andreas, Landoni, Fabio, Rodriguez, Juliana, Manchanda, Ranjit, Kosťun, Jan, dos Reis, Ricardo, Meydanli, Mehmet M., Odetto, Diego, Laky, Rene, Zapardiel, Ignacio, Weinberger, Vit, Benešová, Klára, Borčinová, Martina, Pari, Darwin, Salehi, Sahar, Bizzarri, Nicolò, Akilli, Huseyin, Abu-Rustum, Nadeem R. ... van Lonkhuijzen, Luc R.C.W. (2021). The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. European Journal of Cancer, 158, 111-122. doi: 10.1016/j.ejca.2021.09.008

The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer

2021

Journal Article

Extracellular vesicle-associated miRNAs and chemoresistance: a systematic review

Campos, America, Sharma, Shayna, Obermair, Andreas and Salomon, Carlos (2021). Extracellular vesicle-associated miRNAs and chemoresistance: a systematic review. Cancers, 13 (18) 4608, 4608. doi: 10.3390/cancers13184608

Extracellular vesicle-associated miRNAs and chemoresistance: a systematic review

2021

Journal Article

1429Impact of BRCA mutation status and lifestyle factors on survival among women with ovarian cancer

Gersekowski, Kate, Jordan, Susan, Delahunty, Rachel, Alsop, Kathryn, Goode, Ellen L, Bowtell, David, DeFazio, Anna, Friedlander, Michael, Obermair, Andreas, Grant, Peter and Group, Penelope Webb The OPAL Study (2021). 1429Impact of BRCA mutation status and lifestyle factors on survival among women with ovarian cancer. International Journal of Epidemiology, 50 (Supplement_1). doi: 10.1093/ije/dyab168.217

1429Impact of BRCA mutation status and lifestyle factors on survival among women with ovarian cancer

2021

Journal Article

Development of a multi-institutional prediction model for three-year survival status in patients with uterine leiomyosarcoma (AGOG11-022/QCGC1302 study)

Tse, Ka-Yu, Wong, Richard Wing-Cheuk, Chao, Angel, Ueng, Shir-Hwa, Yang, Lan-Yan, Cummings, Margaret, Smith, Deborah, Lai, Chiung-Ru, Lau, Hei-Yu, Yen, Ming-Shyen, Cheung, Annie Nga-Yin, Leung, Charlotte Ka-Lun, Chan, Kit-Sheung, Chan, Alice Ngot-Htain, Li, Wai-Hon, Choi, Carmen Ka-Man, Pong, Wai-Mei, Hui, Hoi-Fong, Yuk, Judy Ying-Wah, Yao, Hung, Yuen, Nancy Wah-Fun, Obermair, Andreas, Lai, Chyong-Huey, Ip, Philip Pun-Ching and Ngan, Hextan Yuen-Sheung (2021). Development of a multi-institutional prediction model for three-year survival status in patients with uterine leiomyosarcoma (AGOG11-022/QCGC1302 study). Cancers, 13 (10) 2378, 2378. doi: 10.3390/cancers13102378

Development of a multi-institutional prediction model for three-year survival status in patients with uterine leiomyosarcoma (AGOG11-022/QCGC1302 study)

2021

Journal Article

Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer

Moloney, Kristen, Janda, Monika, Frumovitz, Michael, Leitao, Mario, Abu-Rustum, Nadeem R., Rossi, Emma, Nicklin, James L., Plante, Marie, Lecuru, Fabrice R., Buda, Alessandro, Mariani, Andrea, Leung, Yee, Ferguson, Sarah Elizabeth, Pareja, Rene, Kimmig, Rainer, Tong, Pearl Shuang Ye, McNally, Orla, Chetty, Naven, Liu, Kaijiang, Jaaback, Ken, Lau, Julio, Ng, Soon Yau Joseph, Falconer, Henrik, Persson, Jan, Land, Russell, Martinelli, Fabio, Garrett, Andrea, Altman, Alon, Pendlebury, Adam ... Obermair, Andreas (2021). Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer. International Journal of Gynecological Cancer, 31 (5), 647-655. doi: 10.1136/ijgc-2020-002315

Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer

2021

Journal Article

Paucity of data evaluating patient centred outcomes following sentinel lymph node dissection in endometrial cancer: a systematic review

Obermair, Helena M., O'Hara, Montana, Obermair, Andreas and Janda, Monika (2021). Paucity of data evaluating patient centred outcomes following sentinel lymph node dissection in endometrial cancer: a systematic review. Gynecologic Oncology Reports, 36 100763, 100763. doi: 10.1016/j.gore.2021.100763

Paucity of data evaluating patient centred outcomes following sentinel lymph node dissection in endometrial cancer: a systematic review

2021

Journal Article

Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial

Janda, Monika, Robledo, Kristy P., Gebski, Val, Armes, Jane E., Alizart, Michelle, Brennan, Donal, Cummings, Margaret, Chen, Chen, Leung, Yee, Sykes, Peter, McNally, Orla, Oehler, Martin K., Walker, Graeme, Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James L., Chetty, Naven, Perrin, Lewis C., Hoet, Greet, Sowden, Katherine, Eva, Lois, Tristram, Amanda and Obermair, Andreas (2021). Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial. Gynecologic Oncology, 161 (1), 143-151. doi: 10.1016/j.ygyno.2021.01.029

Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial

2021

Journal Article

Physical activity levels among ovarian cancer survivors: a prospective longitudinal cohort study

Jones, Tamara, Sandler, Carolina, Vagenas, Dimitrios, Janda, Monika, Obermair, Andreas and Hayes, Sandra (2021). Physical activity levels among ovarian cancer survivors: a prospective longitudinal cohort study. International Journal of Gynecological Cancer, 31 (4), 553-561. doi: 10.1136/ijgc-2020-002107

Physical activity levels among ovarian cancer survivors: a prospective longitudinal cohort study

2021

Journal Article

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Kang, Eun Young, Cheasley, Dane, LePage, Cecile, Wakefield, Matthew J., da Cunha Torres, Michelle, Rowley, Simone, Salazar, Carolina, Xing, Zhongyue, Allan, Prue, Bowtell, David D. L., Mes-Masson, Anne-Marie, Provencher, Diane M., Rahimi, Kurosh, Kelemen, Linda E., Fasching, Peter A., Doherty, Jennifer A., Goodman, Marc T., Goode, Ellen L., Deen, Suha, Pharoah, Paul D. P., Brenton, James D., Sieh, Weiva, Mateoiu, Constantina, Sundfeldt, Karin, Cook, Linda S., Le, Nhu D., Anglesio, Michael S., Gilks, C. Blake, Huntsman, David G. ... Campbell, Ian G. (2021). Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern Pathology, 34 (1), 194-206. doi: 10.1038/s41379-020-0618-9

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

2021

Journal Article

Corrigendum to “Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial” [Gynecologic Oncology 161 (2021) 143–151](S0090825821000895)(10.1016/j.ygyno.2021.01.029)

Janda, Monika, Robledo, Kristy P., Gebski, Val, Armes, Jane E., Alizart, Michelle, Brennan, Donal, Cummings, Margaret, Chen, Chen, Leung, Yee, Sykes, Peter, McNally, Orla, Oehler, Martin K., GraemeWalker, , Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James L., Chetty, Naven, Perrin, Lewis C., Hoet, Greet, Sowden, Katherine, Eva, Lois, Tristram, Amanda and Obermair, Andreas (2021). Corrigendum to “Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial” [Gynecologic Oncology 161 (2021) 143–151](S0090825821000895)(10.1016/j.ygyno.2021.01.029). Gynecologic Oncology, 162 (2), 526-526. doi: 10.1016/j.ygyno.2021.05.016

Corrigendum to “Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial” [Gynecologic Oncology 161 (2021) 143–151](S0090825821000895)(10.1016/j.ygyno.2021.01.029)

2020

Journal Article

Long-term quality of life outcomes of women treated for early-stage endometrial cancer

Sanjida, Saira, Obermair, Andreas, Gebski, Val, Armfield, Nigel and Janda, Monika (2020). Long-term quality of life outcomes of women treated for early-stage endometrial cancer. International Journal of Gynecologic Cancer, 31 (4), 530-536. doi: 10.1136/ijgc-2020-002145

Long-term quality of life outcomes of women treated for early-stage endometrial cancer

2020

Journal Article

Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Yao, Shih-Ern, Tripcony, Lee, Sanday, Karen, Robertson, Jessica, Perrin, Lewis, Chetty, Naven, Land, Russell, Garrett, Andrea, Obermair, Andreas, Nascimento, Marcelo, Tang, Amy, Jagasia, Nisha, Singh, Piksi and Nicklin, Jim (2020). Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer. International Journal of Gynecological Cancer, 30 (12), 1935-1942. doi: 10.1136/ijgc-2020-001658

Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer

2020

Journal Article

When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer

Beesley, Vanessa L., Webber, Kate, Nagle, Christina M., DeFazio, Anna, Obermair, Andreas, Williams, Merran, Friedlander, Michael and Webb, Penelope M. (2020). When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer. Gynecologic Oncology, 159 (1), 179-186. doi: 10.1016/j.ygyno.2020.07.029

When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer

2020

Journal Article

Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: a metanalysis

Bartels, Helena C., Rogers, Ailin C., Janda, Monika, Obermair, Andreas and Brennan, Donal J. (2020). Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: a metanalysis. European Journal of Obstetrics and Gynecology and Reproductive Biology, 252, 206-212. doi: 10.1016/j.ejogrb.2020.06.055

Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: a metanalysis

2020

Journal Article

A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy

Allanson, Emma R., Peng, Yang, Choi, Angela, Hayes, Sandra, Janda, Monika and Obermair, Andreas (2020). A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy. International Journal of Gynecological Cancer, 30 (11), 1791-1797. doi: 10.1136/ijgc-2020-001678

A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy

2020

Journal Article

Can a symptom checklist improve the triage of patients following successful endometrial cancer treatment?

Peng, Yang, Janda, Monika and Obermair, Andreas (2020). Can a symptom checklist improve the triage of patients following successful endometrial cancer treatment?. Gynecologic Oncology Reports, 33 100604, 100604. doi: 10.1016/j.gore.2020.100604

Can a symptom checklist improve the triage of patients following successful endometrial cancer treatment?

2020

Journal Article

Physical activity trajectories following gynecological cancer: results from a prospective, longitudinal cohort study

Fleming, Steven, Jones, Tamara, Janda, Monika, Vagenas, Dimitrios, Ward, Leigh, Reul-Hirche, Hildegard, Sandler, Carolina, Obermair, Andreas and Hayes, Sandra (2020). Physical activity trajectories following gynecological cancer: results from a prospective, longitudinal cohort study. International Journal of Gynecologic Cancer, 30 (11), 1784-1790. doi: 10.1136/ijgc-2020-001543

Physical activity trajectories following gynecological cancer: results from a prospective, longitudinal cohort study

2020

Journal Article

Fertility-sparing treatment in early endometrial cancer: current state and future strategies

Obermair, Andreas, Baxter, Eva, Brennan, Donal J., McAlpine, Jessica N., Muellerer, Jennifer J., Amant, Frédéric, van Gent, Mignon D. J. M., Coleman, Robert L., Westin, Shannon N., Yates, Melinda S., Krakstad, Camilla and Janda, Monika (2020). Fertility-sparing treatment in early endometrial cancer: current state and future strategies. Obstetrics and Gynecology Science, 63 (4), 417-431. doi: 10.5468/ogs.19169

Fertility-sparing treatment in early endometrial cancer: current state and future strategies

2020

Journal Article

A healthy lifestyle and survival among women with ovarian cancer

Hansen, Jessy M., Nagle, Christina M., Ibiebele, Torukiri I., Grant, Peter T., Obermair, Andreas, Friedlander, Michael L., DeFazio, Anna and Webb, Penelope M. (2020). A healthy lifestyle and survival among women with ovarian cancer. International Journal of Cancer, 147 (12) ijc.33155, 3361-3369. doi: 10.1002/ijc.33155

A healthy lifestyle and survival among women with ovarian cancer